Restless Legs Syndrome Clinical Trials

• Swiss Restless Legs Syndrome Trial (SRLS)
  ClinicalTrials.gov Identifier: NCT00144209 - Active, not recruiting
  Restless Legs Syndrome
  
• Cross-Sectional Study: Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the Legs
  ClinicalTrials.gov Identifier: NCT00557258 - Active, not recruiting
  Restless Legs Syndrome
  
• Relationship Between Sensory and Motor Systems in Restless Leg Syndrome
  ClinicalTrials.gov Identifier: NCT00074672 - Active, not recruiting
  Restless Legs Syndrome
  
• A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
  Restless Legs Syndrome
  
• An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00263068 - Active, not recruiting
  Restless Legs Syndrome
  
• Non-Interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life
  ClinicalTrials.gov Identifier: NCT00539461 - Active, not recruiting
  Restless Legs Syndrome
  
• Long-Term Study of XP13512 vs. Placebo in Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00311363 - Active, not recruiting
  Restless Legs Syndrome
  
• Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
  ClinicalTrials.gov Identifier: NCT00367822 - Active, not recruiting
  Restless Legs Syndrome
  
• Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00355641 - Recruiting
  Restless Legs Syndrome
  
• Restless Legs Syndrome Exercise Intervention
  ClinicalTrials.gov Identifier: NCT00258492 - Active, not recruiting
  Restless Legs Syndrome; Insomnia; Daytime Sleepiness
  
• XP13512 vs. Placebo in Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00365352 - Active, not recruiting
  Restless Legs Syndrome
  
• A Randomized, Double-Blind, Placebo-Controlled Trial with 0.75mg Pramipexole (BI•Sifrol®) Orally Once Daily to Investigate the Efficacy and Safety for 6 Weeks in Patients with Primary Restless Legs Syndrome.
  ClinicalTrials.gov Identifier: NCT00152997 - Completed
  Restless Legs Syndrome
  
• Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
  Restless Legs Syndrome
  
• Long-Term Study Of Ropinirole In Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00329602 - Recruiting
  Restless Legs Syndrome
  
• XP13512 Extension Study in Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00333359 - Recruiting
  Restless Legs Syndrome
  
• SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
  ClinicalTrials.gov Identifier: NCT00344994 - Recruiting
  Restless Legs Syndrome
  
• A Double-Blind, Placebo-Controlled, Randomised Withdrawal Study of 3 Month Duration in Patients Suffering from Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-Month Treatment with Open-Label Pramipexole Including Titration (0.125, 0.25,
  ClinicalTrials.gov Identifier: NCT00152958 - Completed
  Restless Legs Syndrome
  
• Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00051961 - Completed
  Restless Legs Syndrome
  
• Botulinum Toxin to Treat Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00479154 - Recruiting
  Restless Legs Syndrome
  
• ASP8825 - Study in Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00530530 - Recruiting
  Restless Legs Syndrome
  
• The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00357097 - Recruiting
  Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)
  
• A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00275236 - Completed
  Restless Legs Syndrome
  
• A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
  ClinicalTrials.gov Identifier: NCT00247364 - Completed
  Restless Legs Syndrome
  
• Efficacy and Safety of PPX (Pramipexole) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients
  ClinicalTrials.gov Identifier: NCT00275457 - Completed
  Restless Legs Syndrome
  
• Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS).
  ClinicalTrials.gov Identifier: NCT00239486 - Completed
  Restless Legs Syndrome
  
• Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00199446 - Completed
  Sleep Disorder; Restless Legs Syndrome
  
• A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
  ClinicalTrials.gov Identifier: NCT00225862 - Completed
  Restless Legs Syndrome
  
• A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00363857 - Completed
  Restless Legs Syndrome
  
• Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00197080 - Completed
  Restless Legs Syndrome
  
• Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00200941 - Completed
  Restless Legs Syndrome
  
• Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food
  ClinicalTrials.gov Identifier: NCT00419692 - Completed
  Restless Legs Syndrome
  
• 12-Week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00373542 - Completed
  Restless Legs
  
• XP13512 Versus Placebo in Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00298623 - Completed
  Restless Legs Syndrome
  
• Sequential Compression Devices for Treatment of Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00479531 - Completed
  Restless Legs Syndrome
  
• A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Trial Comparing Fixed Doses of 0.25 Mg, 0.50 Mg and 0.75 Mg Pramipexole (Mirapex®) Administered Orally to Investigate the Safety and Efficacy in Patients with Idiopathic Restless
  ClinicalTrials.gov Identifier: NCT00133198 - Completed
  Restless Legs Syndrome
  
• Phase 3 Open-Label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
  ClinicalTrials.gov Identifier: NCT00498108 - Completed
  Idiopathic Restless Legs Syndrome
  
• Rotigotine Restless Legs Syndrome Dose Finding Trial
  ClinicalTrials.gov Identifier: NCT00243217 - Completed
  Idiopathic Restless Leg Syndrome
  
• A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIVE-ARM PARALLEL-GROUP TRIAL TO INVESTIGATE THE EFFICACYAND SAFETY OF FOUR DIFFERENT TRANSDERMAL DOSES OF ROTIGOTINE IN SUBJECTS WITH IDIOPATHIC RESTLESS LEGS SYNDROME
  ClinicalTrials.gov Identifier: NCT00135993 - Completed
  Idiopathic Restless Leg syndrome
  
• Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
  ClinicalTrials.gov Identifier: NCT00256854 - Completed
  Restless Legs Syndrome
  
• A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.
  ClinicalTrials.gov Identifier: NCT00390689 - Active, not recruiting
  Restless Legs Syndrome
  
• A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS
  ClinicalTrials.gov Identifier: NCT00375284 - Active, not recruiting
  Restless Legs Syndrome
  
• Long-Term Open-Label Trial in Idiopathic RLS Subjects
  ClinicalTrials.gov Identifier: NCT00498186 - Active, not recruiting
  Idiopathic Restless Legs Syndrome
  
• Long-Term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe RLS
  ClinicalTrials.gov Identifier: NCT00472199 - Recruiting
  Restless Legs Syndrome
  
• Comprehensive Police Fatigue Management Program
  ClinicalTrials.gov Identifier: NCT00246051 - Not yet recruiting
  Sleep Disorders; Sleep Apnea, Obstructive; Restless Legs Syndrome; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders
  
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
  ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
  Restless Legs Syndrome
  
• A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Proof-of-Concept Trial to Assess the Efficacy, Safety and Tolerability of Ascending Doses of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms in Subjects With Idiopathic Restless
  ClinicalTrials.gov Identifier: NCT00389831 - Completed
  Idiopathic Restless Legs Syndrome
  
• Sleep Disorders Management, Health and Safety in Police
  ClinicalTrials.gov Identifier: NCT00207285 - Recruiting
  Sleep Disorders; Sleep Apnea, Obstructive; Restless Legs Syndrome; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders
  
• Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances
  ClinicalTrials.gov Identifier: NCT00356096 - Completed
  Restless Legs Syndrome; Depression
  
• A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS
  ClinicalTrials.gov Identifier: NCT00349531 - Completed
  Restless Legs Syndrome
  
• Akathisia (Restless Legs Syndrome) in People with Schizophrenia and Mental Retardation
  ClinicalTrials.gov Identifier: NCT00065286 - Completed
  Akathisia
  
• Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
  ClinicalTrials.gov Identifier: NCT00001453 - Active, not recruiting
  Cushing's Syndrome
  
• Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
  ClinicalTrials.gov Identifier: NCT00004343 - Active, not recruiting
  Cushing's Syndrome
  
• IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
  ClinicalTrials.gov Identifier: NCT00368173 - Active, not recruiting
  Growth Hormone Insensitivity Syndrome (GHIS); Laron Syndrome
  
• Amifostine in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003048 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome
  
• Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00004341 - Active, not recruiting
  X-linked agammaglobulinemia; X-linked hyper IgM syndrome; Wiskott-Aldrich Syndrome; Leukocyte Adhesion Deficiency Syndrome
  
• Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003984 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
  
• Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
  ClinicalTrials.gov Identifier: NCT00006445 - Active, not recruiting
  Down Syndrome; Chromosome Abnormalities
  
• Anti-CD20 Antibody Therapy for Sjogren's Syndrome
  ClinicalTrials.gov Identifier: NCT00101829 - Active, not recruiting
  Sjogren's Syndrome
  
• Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003959 - Active, not recruiting
  Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; ...
  
• Modafinil to Treat Fatigue in Post-Polio Syndrome
  ClinicalTrials.gov Identifier: NCT00067496 - Active, not recruiting
  Postpoliomyelitis Syndrome
  
• The effect of androgen and growth hormone on height and learning in girls with Turner syndrome
  ClinicalTrials.gov Identifier: NCT00029159 - Active, not recruiting
  Turner Syndrome
  
• MPS I Registry
  ClinicalTrials.gov Identifier: NCT00144794 - Recruiting
  Mucopolysaccharidosis I; Hurler''s Syndrome; Hurler-Scheie Syndrome; Scheie Syndrome
  
• Amifostine With or Without Epoetin alfa in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003681 - Active, not recruiting
  Refractory Anemia; Previously Treated Myelodysplastic Syndrome; Anemia; secondary myelodysplastic syndrome; ...
  
• Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
  ClinicalTrials.gov Identifier: NCT00048854 - Active, not recruiting
  Premenstrual Syndrome
  
• Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003790 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; untreated childhood acute myeloid leukemia; secondary myelodysplastic syndrome; ...
  
• Carperitide in Acute Respiratory Distress Syndrome (ARDS)
  ClinicalTrials.gov Identifier: NCT00030121 - Active, not recruiting
  Respiratory Distress Syndrome
  
• Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00033137 - Recruiting
  Syndrome
  
• Manifestations of Heritable Disorders of Connective Tissue
  ClinicalTrials.gov Identifier: NCT00270686 - Recruiting
  Ehlers-Danlos Syndrome; Marfan Syndrome; Stickler Syndrome
  
• Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00008450 - Recruiting
  Purine-Pyrimidine Metabolism, Inborn Errors; Wiskott-Aldrich Syndrome; Bare Lymphocyte Syndrome; Lymphopenia; Job's Syndrome; DiGeorge Syndrome; ...
  
• Pioglitazone Treatment in Polycystic Ovary Syndrome
  ClinicalTrials.gov Identifier: NCT00145340 - Active, not recruiting
  Polycystic Ovary Syndrome
  
• Down Syndrome and Continuous Positive Pressure Therapy
  ClinicalTrials.gov Identifier: NCT00394290 - Recruiting
  Down Syndrome; Obstructive Sleep Apnea Syndrome
  
• Study of Tics in Patients with Tourette's Syndrome and Chronic Motor Tic Disorder
  ClinicalTrials.gov Identifier: NCT00033995 - Active, not recruiting
  Tourette Syndrome; Tic Disorders
  
• Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
  ClinicalTrials.gov Identifier: NCT00303004 - Active, not recruiting
  Eisenmenger Syndrome
  
• Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome
  ClinicalTrials.gov Identifier: NCT00452725 - Active, not recruiting
  Noonan Syndrome
  
• Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
  ClinicalTrials.gov Identifier: NCT00543166 - Active, not recruiting
  Sjogren's Syndrome
  
• Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
  ClinicalTrials.gov Identifier: NCT00006054 - Active, not recruiting
  Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; ...
  
• Vitamin E in Aging Persons With Down Syndrome
  ClinicalTrials.gov Identifier: NCT00056329 - Active, not recruiting
  Down Syndrome; Alzheimer Disease
  
• Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
  ClinicalTrials.gov Identifier: NCT00097370 - Active, not recruiting
  Hypereosinophilic Syndrome; Hypereosinophilia
  
• Study of the Safety and Efficacy of CC-5013 Treatment For Patients with Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00044382 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
  ClinicalTrials.gov Identifier: NCT00433485 - Active, not recruiting
  Neoplastic Syndrome; Non-Melanomatous Skin Cancer
  
• Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00182208 - Active, not recruiting
  Postphlebitic Syndrome
  
• Study of High-dose Pulse Administration DN-101 (Calcitriol) in Patients with Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00057031 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Antiphospholipid Syndrome Collaborative Registry (APSCORE)
  ClinicalTrials.gov Identifier: NCT00076713 - Active, not recruiting
  Antiphospholipid Syndrome
  
• Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
  ClinicalTrials.gov Identifier: NCT00068913 - Active, not recruiting
  MELAS Syndrome
  
• Management of Compartment Syndrome with Ultrafiltration
  ClinicalTrials.gov Identifier: NCT00022815 - Active, not recruiting
  Compartment Syndrome
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
  ClinicalTrials.gov Identifier: NCT00003662 - Active, not recruiting
  Graft Versus Host Disease; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
  
• Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00140244 - Active, not recruiting
  HAART-induced lipodystrophy and metabolic syndrome
  
• Carpal Tunnel Syndrome: Diagnosis and Treatment Trial
  ClinicalTrials.gov Identifier: NCT00032227 - Active, not recruiting
  Carpal Tunnel Syndrome
  
• A Phase 4 Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG Levels in Aldurazyme® (Laronidase) Treated Patients.
  ClinicalTrials.gov Identifier: NCT00144768 - Recruiting
  Mucopolysaccharidosis I; Hurler''s Syndrome; Hurler-Scheie Syndrome; Scheie Syndrome
  
• Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00008151 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
  
• Retraining Walking after Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00059553 - Active, not recruiting
  Spinal Cord Injuries; Quadriplegia; Paraplegia; Central Cord Syndrome; Brown-Sequard Syndrome
  
• Study of GABA-A receptors in the Generation of Tics in Patients with Tourette's Syndrome
  ClinicalTrials.gov Identifier: NCT00034398 - Recruiting
  Tourette Syndrome
  
• Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
  ClinicalTrials.gov Identifier: NCT00006056 - Active, not recruiting
  Chediak-Higashi Syndrome; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; ...
  
• Sleep Disordered Breathing in Gulf War Syndrome Veterans and the Effect of Continuous Positive Airway Pressure (CPAP) Treatment
  ClinicalTrials.gov Identifier: NCT00252629 - Recruiting
  Gulf War Syndrome; Chronic Fatigue Syndrome; Functional Somatic Syndrome; Upper Airway Resistance Syndrome; Sleep Apnea
  
• Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection (Job Syndrome)
  ClinicalTrials.gov Identifier: NCT00006150 - Recruiting
  Job's Syndrome
  
• Topotecan in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003675 - Active, not recruiting
  Refractory Anemia; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; de novo myelodysplastic syndrome; ...
  
• An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urgency-Frequency Syndrome
  ClinicalTrials.gov Identifier: NCT00131573 - Active, not recruiting
  Urinary Urgency-Frequency Syndrome
  
• Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00350064 - Active, not recruiting
  Metabolic Syndrome
  
• CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors
  ClinicalTrials.gov Identifier: NCT00399399 - Active, not recruiting
  Churg-Strauss Syndrome
  
• Risk of Guillain-Barré Syndrome Following Meningococcal Conjugate (MCV4) Vaccination Menactra and GBS
  ClinicalTrials.gov Identifier: NCT00575653 - Active, not recruiting
  Guillain-Barre Syndrome